Biomea Fusion is a biotechnology business based in the US. Biomea Fusion shares (BMEA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.99 – a decrease of 21.03% over the previous week. Biomea Fusion employs 107 staff and has a market cap (total outstanding shares value) of 0.00.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.99 |
|---|---|
| 52-week range | $2.27 - $14.43 |
| 50-day moving average | $3.33 |
| 200-day moving average | $5.97 |
| Wall St. target price | $23.67 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-4.01 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.13 from 2025-03-31
| 1 week (2025-03-26) | -15.48% |
|---|---|
| 1 month (2025-03-03) | -19.32% |
| 3 months (2025-01-03) | -42.90% |
| 6 months (2024-10-03) | -78.89% |
| 1 year (2024-04-02) | -83.36% |
|---|---|
| 2 years (2023-03-31) | -93.13% |
| 3 years (2022-04-01) | 4.41 |
| 5 years (2020-03-30) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -56.38% |
| Return on equity TTM | -104.51% |
| Profit margin | 0% |
| Book value | $2.10 |
| Market Capitalization | $83.3 million |
TTM: trailing 12 months
We're not expecting Biomea Fusion to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Biomea Fusion's shares have ranged in value from as little as $2.27 up to $14.43. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biomea Fusion's is -0.278. This would suggest that Biomea Fusion's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biomea Fusion has bucked the trend.
To put Biomea Fusion's beta into context you can compare it against those of similar companies.
Biomea Fusion, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California. .
See 5 stocks that could withstand trade tensions in 2025, offering stability amid tariffs and global supply shifts.
Learn how to buy the SoFi Select 500 ETF with these step-by-step instructions.
Learn how and where to buy Fannie Mae (FNMA) stock, view trends and see what may be ahead for share holders.
See how and where to buy Freddie Mac (FMCC) stock, view past price performance and learn what’s ahead for shareholders.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
A deep dive into the highlights and limitations of Robinhood.